                         SEQUENCE LISTING

<110>  Van Snick, Jacques
 
<120>  TGF-B1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF

<130>  2332-1-026PCT

<140>  UNASSIGNED
<141>  2013-03-06

<150>  61/608,393
<151>  2012-03-08

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  115
<212>  PRT
<213>  Mus musculus

<400>  1

Leu Ala Arg Pro Gly Ala Ser Val Lys Met Ser Cys Lys Thr Ser Gly 
1               5                   10                  15      


Tyr Thr Phe Thr Asn Tyr Trp Met His Trp Val Arg Gln Arg Pro Gly 
            20                  25                  30          


Gln Gly Leu Glu Trp Ile Gly Thr Ile Tyr Pro Gly Asn Ser Asp Thr 
        35                  40                  45              


Asn Tyr Asn Gln Lys Phe Lys Asp Lys Ala Lys Leu Thr Ala Val Thr 
    50                  55                  60                  


Ser Ala Thr Thr Ala Tyr Met Glu Leu Ser Ser Leu Thr Asn Glu Asp 
65                  70                  75                  80  


Ser Ala Val Tyr Phe Cys Thr Arg Glu Asp Ser Arg Ser Leu Tyr Tyr 
                85                  90                  95      


Asn Gly Trp Asp Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Thr Leu Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210>  2
<211>  108
<212>  PRT
<213>  Mus musculus

<400>  2

Leu Thr Gln Ser Pro Ala Ser Leu Ala Val Ser Leu Gly Gln Arg Ala 
1               5                   10                  15      


Thr Ile Ser Cys Arg Ala Ser Glu Ser Val Asp Asn Tyr Gly Ile Ser 
            20                  25                  30          


Phe Leu Asn Trp Phe Gln Gln Lys Pro Gly Gln Pro Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ala Ala Ser Asn Gln Gly Ser Gly Val Pro Ala Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Ser Leu Asn Ile His Pro Met Glu 
65                  70                  75                  80  


Glu Asp Asp Thr Gly Met Tyr Phe Cys Gln Gln Ser Lys Glu Val Pro 
                85                  90                  95      


Arg Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Ile 
            100                 105             


<210>  3
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  3

Gly Tyr Thr Phe Thr Asn Tyr Trp Met His 
1               5                   10  


<210>  4
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  4

Thr Ile Tyr Pro Gly Asn Ser Asp Thr Asn 
1               5                   10  


<210>  5
<211>  16
<212>  PRT
<213>  Mus musculus

<400>  5

Glu Asp Ser Arg Ser Leu Tyr Tyr Asn Gly Trp Asp Tyr Phe Asp Tyr 
1               5                   10                  15      


<210>  6
<211>  10
<212>  PRT
<213>  Mus musculus

<400>  6

Glu Ser Val Asp Asn Tyr Gly Ile Ser Phe 
1               5                   10  


<210>  7
<211>  4
<212>  PRT
<213>  Mus musculus

<400>  7

Tyr Ala Ala Ser 
1               


<210>  8
<211>  9
<212>  PRT
<213>  Mus musculus

<400>  8

Gln Gln Ser Lys Glu Val Pro Arg Thr 
1               5                   


<210>  9
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PADRE peptide


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  9

Ala Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala Cys 
1               5                   10              


<210>  10
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Tetanus Toxin peptide

<400>  10

Cys Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15      


<210>  11
<211>  8
<212>  PRT
<213>  Mus musculus

<400>  11

Gly Tyr Thr Phe Thr Asn Tyr Trp 
1               5               


<210>  12
<211>  8
<212>  PRT
<213>  Mus musculus

<400>  12

Ile Tyr Pro Gly Asn Ser Asp Thr 
1               5               


